Biotech startups in Colorado, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Arpeggio Bio | Boulder | Series A | $20.0M | 2025-11-19 |
| Pluto Biosciences | Denver | Seed | $3.6M | 2025-05-13 |
| Limitless AI (formerly Rewind AI) | Denver | Series A | $17.9M | 2023-05-11 |
| Ambrosia Biosciences | Boulder | Series B | $100.0M | 2026-03-31 |
| Kromatid | Longmont | Series C | $8.0M | 2025-08-20 |
| Think Bioscience | Boulder | Series A | $55.0M | 2026-01-20 |
| BioLoomics | Boulder | Seed | $8.7M | 2023-09-19 |
| Foresight Diagnostics | Denver | Series B | $33.0M | 2024-07-30 |
8 rows of the CSV in 5 of its 18 columns.
- The 93 biotech startups in Colorado, United States have raised $2.5B in total.
- 11 of them closed their most recent round in the last 12 months, $511.0M combined.
- The largest of those rounds is Enveda's $311.0M Series E, dated September 2026.
- Andreessen Horowitz is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 74 companies (80%).
- 30% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (52% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 93| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Ambrosia Biosciences | Ambrosia Biosciences provides drug development services for small molecule therapies targeting obesity and metabolic disorders. | Biotech | Boulder | Series B | $100.0M | 2026-03-31 | $141.0M | Boulder Ventures, Biotechnology Value Fund | 11 to 50 | 2024 |
| Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Boulder | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| Arpeggio Bio | Arpeggio Bio builds technology that observes how drugs work. | Artificial intelligence | Boulder | Series A | $20.0M | 2025-11-19 | $40.4M | Y Combinator, Khosla Ventures, FundersClub +1 | 11 to 50 | 2017 |
| Kromatid | Kromatid develops molecular cytogenetics assays and reagents to study genetic abnormalities and diseases. | Biotech | Longmont | Series C | $8.0M | 2025-08-20 | $28.1M | BroadOak Capital Partners, First Capital Ventures | 11 to 50 | 2007 |
| Pluto Biosciences | Pluto Biosciences offers a collaborative platform for managing, analyzing, and visualizing biological data. | Artificial intelligence | Denver | Seed | $3.6M | 2025-05-13 | $8.3M | Silverton Partners | 11 to 50 | 2020 |
| BioLoomics | BioLoomics is a biotechnology company that develops antibodies for cancer therapies. | Biotech | Boulder | Seed | $8.7M | 2023-09-19 | $10.1M | Horizons Ventures, Innovation Endeavors, Hummingbird Ventures +2 | 11 to 50 | 2019 |
| Limitless | Limitless builds AI-driven products that boost productivity, simplify processes, and deliver business insights. | Artificial intelligence | Denver | Series A | $17.9M | 2023-05-11 | Alumni Ventures, Andreessen Horowitz, New Enterprise Associates +1 | 11 to 50 | 2020 | |
| Limitless AI (formerly Rewind AI) | Limitless AI develops a wearable personal AI assistant that helps people capture, recall, and act on information. | Artificial intelligence | Denver | Series A | $17.9M | 2023-05-11 | $27.9M | Andreessen Horowitz, First Round Capital, Snow Leopard Technology Ventures | 11 to 50 | 2020 |
Table 1. Biotech startups in Colorado, United States: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 93.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ambrosia Biosciences | Ambrosia Biosciences provides drug development services for small molecule therapies targeting obesity and metabolic disorders. | Biotech | Boulder | Series B | $100.0M | 2026-03-31 | $141.0M | Boulder Ventures, Biotechnology Value Fund | 11 to 50 | 2024 |
| 2 | Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Boulder | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| 3 | Arpeggio Bio | Arpeggio Bio builds technology that observes how drugs work. | Artificial intelligence | Boulder | Series A | $20.0M | 2025-11-19 | $40.4M | Y Combinator, Khosla Ventures, FundersClub +1 | 11 to 50 | 2017 |
Table 2. Biotech startups in Colorado, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 2 | 2% | ||
| 2 | Innovation Endeavors | Venture capital firm | Palo Alto, United States | 2 | 2% | 1 | Think Bioscience |
| 3 | Alumni Ventures | Angel group | Manchester, United States | 1 | 1% | ||
| 4 | Vela Partners | Venture capital firm | San Francisco, United States | 1 | 1% | ||
| 5 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | 1 | 1% | ||
| 6 | FundersClub | Micro VC fund | San Francisco, United States | 1 | 1% | 1 | Arpeggio Bio |
| 7 | Y Combinator | Startup accelerator | Mountain View, United States | 1 | 1% | 1 | Arpeggio Bio |
| 8 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 1 | 1% | 1 | Arpeggio Bio |
| 9 | Builders VC | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | Arpeggio Bio |
| 10 | Silverton Partners | Venture capital firm | Austin, United States | 1 | 1% | ||
| 11 | First Round Capital | Venture capital firm | Philadelphia, United States | 1 | 1% | ||
| 12 | Snow Leopard Technology Ventures | Venture capital firm | Pune, India | 1 | 1% | ||
| 13 | Boulder Ventures | Venture capital firm | Boulder, United States | 1 | 1% | 1 | Ambrosia Biosciences |
| 14 | Biotechnology Value Fund | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | Ambrosia Biosciences |
| 15 | BroadOak Capital Partners | Investment bank | Bethesda, United States | 1 | 1% |
Table 3. Biotech startups in Colorado, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 74 | 80% | $2.2B |
| Software | 15 | 16% | $952.1M |
| Artificial intelligence | 9 | 10% | $923.3M |
| Hardware | 9 | 10% | $135.0M |
| Energy | 3 | 3% | $162.5M |
| Commerce | 2 | 2% | $20.0M |
| Cybersecurity | 1 | 1% | $37.2M |
Table 4. Biotech startups in Colorado, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 5 | 5% | $540K |
| Seed | 47 | 51% | $525K |
| Series A | 15 | 16% | $17.9M |
| Series B | 12 | 13% | $12.0M |
| Series C | 8 | 9% | $36.5M |
| Series D+ | 6 | 6% | $40.0M |
Table 5. Biotech startups in Colorado, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups in Colorado, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 9% | $311.0M |
| August 2026 | 2 | 18% | $4.7M |
| July 2026 | 1 | 9% | $4.0M |
| June 2026 | 1 | 9% | $250K |
| April 2026 | 2 | 18% | $1.0M |
| March 2026 | 1 | 9% | $100.0M |
| January 2026 | 1 | 9% | $55.0M |
| December 2025 | 1 | 9% | $15.0M |
| November 2025 | 1 | 9% | $20.0M |
Table 7. Biotech startups in Colorado, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 9 | 10% | $475.9M |
| 2025 | 11 | 12% | $80.0M |
| 2024 | 9 | 10% | $69.0M |
| 2023 | 9 | 10% | $116.8M |
| 2022 | 6 | 6% | $174.4M |
| 2021 | 4 | 4% | $16.7M |
Table 8. Biotech startups in Colorado, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 11 | 12% |
| 2020 to 2022 | 17 | 18% |
| 2015 to 2019 | 27 | 29% |
| 2010 to 2014 | 18 | 19% |
| Before 2010 | 20 | 22% |
Table 9. Biotech startups in Colorado, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 48 | 52% |
| 11 to 50 | 31 | 34% |
| 51 to 100 | 9 | 10% |
| 101 to 250 | 2 | 2% |
| 251 to 500 | 2 | 2% |
Table 10. Biotech startups in Colorado, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Colorado, United States. On 16 November 2026 that is 93 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 93 rows: 16 have no round amount, 0 no city and 18 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Colorado, United States are on the list?
- 93, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 93 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.